N/A
Manufactured by Aurobindo Pharma Limited
45,890 FDA adverse event reports analyzed
Last updated: 2026-04-14
MECLIZINE HYDROCHLORIDE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Aurobindo Pharma Limited. The most commonly reported adverse reactions for MECLIZINE HYDROCHLORIDE include DIZZINESS, NAUSEA, FATIGUE, HEADACHE, DIARRHOEA. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for MECLIZINE HYDROCHLORIDE.
Out of 18,822 classified reports for MECLIZINE HYDROCHLORIDE:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.